GV Prasad – CEO, Dr Reddy's Laboratories says that remedial actions at Srikakulam plant are underway as some of the products have already been transferred and some are in the process of getting transferred from Srikakulam. On the company’s Q1 earnings, he says that the results have benefited from the launch of some products in the US and margins will be sustainable depending on competition in the US. Listen in.